Table 3. Multivariate analysis for overall survival in the development set and prognostic score of patients with gastric cancer.
Variables | HR | 95% CI | P value | Score |
---|---|---|---|---|
Age at diagnosis (years) | ||||
< 65 | 1.000 | 0 | ||
≥ 65 | 1.445 | 1.129–1.850 | 0.003 | 1 |
Tumor size | ||||
≤ 4.5 cm | 1.000 | 0 | ||
> 4.5 cm | 1.345 | 1.030–1.756 | 0.030 | 1 |
Lauren type | ||||
Intestinal | 1.000 | 0 | ||
Diffuse | 1.594 | 1.204–2.112 | 0.001 | 1 |
Mixed | 1.435 | 1.026–2.006 | 0.035 | 1 |
Depth of invasion | ||||
T1 | 1.000 | 0 | ||
T2 | 4.136 | 1.537–11.126 | 0.005 | 3 |
T3 | 6.453 | 2.474–16.830 | < 0.001 | 5 |
T4 | 7.567 | 2.974–19.253 | < 0.001 | 6 |
Metastatic LNs, No. | ||||
0 | 1.000 | 0 | ||
1–2 | 1.675 | 1.053–2.667 | 0.030 | 1 |
3–6 | 2.173 | 1.387–3.404 | 0.001 | 2 |
7–15 | 3.774 | 2.456–5.799 | < 0.001 | 3 |
>15 | 4.488 | 2.862–7.039 | < 0.001 | 3 |
NLR | ||||
≤ 1.86 | 1.000 | 0 | ||
> 1.86 | 1.379 | 1.082–1.758 | 0.009 | 1 |
Abbreviations: LNs, lymph nodes; NLR, neutrophil—lymphocyte ratio; HR, hazard ratio; CI, confidence interval.